| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | N05CM13 |
| UNII: | 3O25NRX9YG |
Structure
| InChI Key | QRCJOCOSPZMDJY-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C8H17NO |
| Molecular Weight | 143.23 |
| AlogP | 1.54 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 43.09 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 10.0 |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Bipolar Disorder; Psychotic Disorders | Phase 3 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 4171-13-5 |
| ChEBI | 134767 |
| ChEMBL | CHEMBL1075733 |
| DrugBank | DB13099 |
| DrugCentral | 2802 |
| FDA SRS | 3O25NRX9YG |
| PubChem | 20140 |
| SureChEMBL | SCHEMBL387435 |
CONTENTS